Author: Bertin, Daniel; Brodovitch, Alexandre; Beziane, Abdou; Hug, Sylvia; Bouamri, Afaf; Mege, Jean Louis; Bardin, Nathalie
Title: Antiâ€cardiolipin IgG autoantibodies are an independent risk factor of COVIDâ€19 severity Cord-id: aef1g81a Document date: 2020_6_21
ID: aef1g81a
Snippet: A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVIDâ€19) (1). In addition, the high incidence of thromboembolic events suggests an important role of COVIDâ€19â€induced coagulopathy (2). Antiphospholipid autoantibodies (aPL), that are essential markers for antiphospholipid syndrome, are considered as a cardiovascular risk factor.
Document: A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVIDâ€19) (1). In addition, the high incidence of thromboembolic events suggests an important role of COVIDâ€19â€induced coagulopathy (2). Antiphospholipid autoantibodies (aPL), that are essential markers for antiphospholipid syndrome, are considered as a cardiovascular risk factor.
Search related documents:
Co phrase search for related documents- admission require and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Co phrase search for related documents, hyperlinks ordered by date